SCHEMBL10072419

SCHEMBL10072419

Cc1ccc2c(c1)N(c1ccccc1)c1ccccc1N2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.43
PDE4D Q08499 1/20 0.43
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 2/20 0.38
FGFR1 P11362 2/20 0.36
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
MAOA P21397 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
AGTR1 P30556 1/20 0.33
ADRA2A P08913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12841526 0.96 OPRK1 (0.40) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL11978695 0.93 ALDH1A1 (0.41) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL1611442 0.91 ALDH1A1 (0.42) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL1612154 0.91 ALDH1A1 (0.42) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL12251824 0.84 MAOA (0.44) OPRK1PDE4DALDH1A1LMNAGAA
SCHEMBL18905713 0.83 ALDH1A1 (0.41) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL18905722 0.83 ALDH1A1 (0.41) OPRK1PDE4DALDH1A1KDM4EHSD17B10
SCHEMBL20788946 0.83 ELANE (0.46) ALDH1A1KDM4ELMNAGAATSHR
SCHEMBL12901940 0.82 MAOA (0.43) HSD17B10FGFR1LMNAGAAMAOA
SCHEMBL19001734 0.82 OPRK1 (0.43) OPRK1PDE4DALDH1A1FGFR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
EP-2112214-A1 Dibenzo[g,p]chrysene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 OPRK1 1688/4885PDE4D 2435/4885ALDH1A1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.